"10.1371_journal.pone.0034516","plos one","2012-04-06T00:00:00Z","Michael R Breen; Marta Camps; Francisco Carvalho-Simoes; Antonio Zorzano; Paul F Pilch","Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts, United States of America; Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain; CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Barcelona, Spain; IBUB Institute of Biomedicine of the University of Barcelona, Barcelona, Spain; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, United States of America","Conceived and designed the experiments: MRB MC FCS AZ PFP. Performed the experiments: MRB MC FCS AZ. Analyzed the data: MRB MC FCS AZ PFP. Contributed reagents/materials/analysis tools: MC FCS AZ PFP. Wrote the paper: MRB PFP.","Troglitazone, a gift from Pfizer, Groton, CT, USA, was used in this study. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","04","Michael R Breen","MRB",5,TRUE,5,4,5,2,TRUE,TRUE,FALSE,0,NA,FALSE
